Loading clinical trials...
Loading clinical trials...
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy; a Placebo-controlled Trial
Conditions
Interventions
Aspirin 80mg
Placebo Oral Tablet
Locations
1
Hong Kong
Prince of Wales Hospital
Hong Kong, Hong Kong
Start Date
February 10, 2026
Primary Completion Date
December 31, 2030
Completion Date
December 31, 2031
Last Updated
March 18, 2026
NCT07444957
NCT07436429
NCT07354646
NCT07351825
NCT07320625
NCT07317323
Lead Sponsor
Chinese University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions